Company Filing History:
Years Active: 2023-2025
Title: The Innovations of Benjamin Samelson-Jones
Introduction
Benjamin Samelson-Jones is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of blood coagulation factors. With a total of two patents to his name, his work has the potential to impact therapeutic approaches in hemophilia treatment.
Latest Patents
Samelson-Jones's latest patents include "Compositions and methods for modulating Factor VIII function," which discloses Factor VIII variants and methods of use thereof. Additionally, he holds a patent for "Compositions and methods for modulating Factor IX function," detailing Factor IX/IXa variants and methods of use thereof. These innovations are crucial for advancing treatment options for patients with bleeding disorders.
Career Highlights
He is currently affiliated with The Children's Hospital of Philadelphia, where he continues to engage in groundbreaking research. His work focuses on developing new therapeutic strategies that can enhance the functionality of critical blood factors.
Collaborations
Samelson-Jones collaborates with esteemed colleagues, including Valder R Arruda and Rodney M Camire. Their combined expertise fosters an environment of innovation and discovery in the field of hematology.
Conclusion
Benjamin Samelson-Jones exemplifies the spirit of innovation in biomedical research. His contributions through patents and collaborations are paving the way for advancements in the treatment of blood coagulation disorders.